Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression-Reference-Cited by-同舟云学术

Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression

Published:2005-07-07 Issue:22 Volume:12 Page:1608-1617
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Kuppuswamy M,Spencer J F,Doronin K,Tollefson A E,Wold W S M,Toth K

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3302581.pdf

Reference51 articles.

1. Russell WC . Update on adenovirus and its vectors. J Gen Virol 2000; 81: 2573–2604.

2. Kanerva A, Hemminki A . Modified adenoviruses for cancer gene therapy. Int J Cancer 2004; 110: 475–480.

3. Oosterhoff D, Van Beusechem VW . Conditionally replicating adenoviruses as anticancer agents and ways to improve their efficacy. J Exp Ther Oncol 2004; 4: 37–57.

4. Kirn D, Martuza RL, Zwiebel J . Replication-selective virotherapy for cancer: biological principles, risk management and future directions. Nat Med 2001; 7: 781–787.

5. Haviv YS, Curiel DT . Engineering regulatory elements for conditionally-replicative adeno-viruses. Curr Gene Ther 2003; 3: 357–385.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic Adenovirus, a New Treatment Strategy for Prostate Cancer;Biomedicines;2022-12-15

2. Adenovirus Vector With ADP Gene Induces Cytopathic Effects in HEK293 Cells Without Significant Elevation of Virus Titers;Anticancer Research;2022-03-28

3. Anticancer Immunotherapy: Prospects and Challenges;Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach;2019

4. Current status and future perspectives of fluorescence-guided surgery for cancer;Expert Review of Anticancer Therapy;2015-12-07

5. Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway;Oncotarget;2015-10-19